HealthEquity, Inc. (NASDAQ:HQY – Get Rating) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 4,310,000 shares, an increase of 8.0% from the September 15th total of 3,990,000 shares. Based on an average daily volume of 712,900 shares, the short-interest ratio is presently 6.0 days. Approximately 5.2% of the company’s stock are short sold.Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Market for health savings and related accounts is expected to see sizable growth, which bodes well for HQY long-term. Click here to read why we are hold for this stock now.
The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, makes no bones about it when he says. HealthEquity, Inc. (NASDAQ:HQY – Get Rating) has received a consensus rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and ten. HealthEquity, Inc. (NASDAQ:HQY – Get Rating) EVP Larry L. Trittschuh sold 11,526 shares of the company’s stock in a transaction that occurred on Thursday, October 13th. The stock was sold at an average price of $70.00, for a total value of $806,820.00. Following the completion of the sale, the executive vice president now owns 27,961 shares in the company, valued at approximately $1,957,270. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.HealthEquity’s strong performance in Q3 resulted in 54% growth in investment accounts and 19% growth in invested assets.